BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12450999)

  • 21. Atrial fibrillation and anticoagulant therapy.
    Wheeldon NM
    Eur Heart J; 1995 Mar; 16(3):302-12. PubMed ID: 7789371
    [No Abstract]   [Full Text] [Related]  

  • 22. [Which anticoagulation therapy in old atrial fibrillation patients?].
    Taieb J
    Presse Med; 2013 Jun; 42(6 Pt 1):1015-8. PubMed ID: 23706757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ablation for atrial fibrillation: can we decrease thromboembolism without increasing the risk for bleeding?
    Asirvatham SJ
    Circulation; 2007 Nov; 116(22):2517-9. PubMed ID: 18040036
    [No Abstract]   [Full Text] [Related]  

  • 24. Predicting thromboembolism and selecting patients for anticoagulant therapy in atrial fibrillation.
    Weintraub WS
    J Am Coll Cardiol; 2008 Feb; 51(8):816-7. PubMed ID: 18294565
    [No Abstract]   [Full Text] [Related]  

  • 25. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 26. Stroke prevention in atrial fibrillation – latest guideline recommendations and real world data.
    Johnson V; Schmitt J; Hamm CW
    Med Monatsschr Pharm; 2017 Apr; 40(4):167-70. PubMed ID: 29952167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 28. Angiotensin type 1 receptor blockade prevents endocardial dysfunction of rapidly paced atria in rats.
    Yamashita T; Sekiguchi A; Kato T; Tsuneda T; Iwasaki YK; Sagara K; Iinuma H; Sawada H; Aizawa T
    J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):127-32. PubMed ID: 17907100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The improved but unfinished business of stroke risk stratification in atrial fibrillation.
    Banerjee A; Marín F; Lip GY
    Rev Esp Cardiol; 2011 Aug; 64(8):639-41. PubMed ID: 21684058
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention of thromboembolic complication in atrial fibrillation by using anticoagulants.
    Wagh K; Vikhe VB; Kumar RS; Auti N; Jose M
    J Assoc Physicians India; 2013 Dec; 61(12):894-5. PubMed ID: 24968545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of thromboembolism and bleeding after general surgery in patients with atrial fibrillation.
    Vink R; Rienstra M; van Dongen CJ; Levi M; Büller HR; Crijns HJ; van Gelder IC
    Am J Cardiol; 2005 Sep; 96(6):822-4. PubMed ID: 16169369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Risk of thromboembolism in atrial fibrillation].
    Csanádi Z
    Orv Hetil; 2016 Sep; 157(38):1511-5. PubMed ID: 27640617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticoagulation in atrial fibrillation.
    Huerta BJ; Lemberg L
    Heart Lung; 1985 Sep; 14(5):521-3. PubMed ID: 3849534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Thoughts about anticoagulation in older patients].
    Gil Gregorio P
    Med Clin (Barc); 2016 Aug; 147(4):151-3. PubMed ID: 27068787
    [No Abstract]   [Full Text] [Related]  

  • 35. Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation.
    Kamel H; Okin PM; Longstreth WT; Elkind MS; Soliman EZ
    Future Cardiol; 2015 May; 11(3):323-31. PubMed ID: 26021638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The search for atrial fibrillation and its impact on public health.
    Lam A; Goulouti E; Roten L
    Swiss Med Wkly; 2017; 147():w14447. PubMed ID: 28695554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of risk of thromboembolism in atrial fibrillation: which patients should be anticoagulated?
    Lip GY
    Eur Heart J; 1999 Dec; 20(23):1757-8. PubMed ID: 10562485
    [No Abstract]   [Full Text] [Related]  

  • 38. Managing anticoagulated atrial fibrillation patients undergoing endoscopy.
    Gorard DA
    Gut; 2009 Mar; 58(3):468; author reply 469. PubMed ID: 19211861
    [No Abstract]   [Full Text] [Related]  

  • 39. Anticoagulation in people with atrial fibrillation.
    Fang MC
    BMJ; 2011 Jan; 342():d530. PubMed ID: 21282259
    [No Abstract]   [Full Text] [Related]  

  • 40. [Anticoagulant treatment in the prophylaxis of thromboembolic complications in atrial fibrillation].
    Skrakova M; Sujanova Z
    Bratisl Lek Listy; 2001; 102(5):268-70. PubMed ID: 11725382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.